Loading...
XNYS
CLB
Market cap506mUSD
Jul 09, Last price  
10.99USD
1D
-1.43%
1Q
-33.43%
Jan 2017
-90.84%
Name

Core Laboratories N.V.

Chart & Performance

D1W1MN
XNYS:CLB chart
P/E
17.08
P/S
0.96
EPS
0.64
Div Yield, %
0.36%
Shrs. gr., 5y
0.67%
Rev. gr., 5y
1.56%
Revenues
527m
+0.51%
575,689,000670,540,000780,836,000695,539,000794,653,000907,648,000981,080,0001,073,508,0001,085,222,000797,520,000594,741,000659,809,000700,846,000668,210,000487,267,000470,252,000489,735,000509,790,000523,848,000526,520,000
Net income
30m
-5.51%
82,662,000121,105,000143,603,000113,604,000144,917,000184,684,000216,071,000242,811,000257,485,000114,847,00063,895,00083,125,00079,526,000101,983,000-97,637,00019,727,00019,453,00036,675,00031,400,00029,669,000
CFO
37m
-34.07%
120,305,000125,695,000155,207,000181,873,000205,832,000204,126,000237,202,000298,137,000303,449,000219,100,000131,887,000124,271,000111,827,00089,527,00057,868,00036,579,00024,956,00024,789,00056,388,00037,176,000
Dividend
Nov 03, 20250.01 USD/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Core Laboratories N.V. (CLB) is a global provider to the oil and gas sector, delivering specialized services and products for characterizing subterranean reservoirs and optimizing hydrocarbon extraction. The company's operations are distinctly segmented into Reservoir Description and Production Enhancement. The Reservoir Description division meticulously analyzes petroleum reservoir rock, fluid, and gas samples. This detailed scientific examination aims to boost the yield and enhance the recovery of oil and gas from clients' reservoirs. Offerings in this segment encompass comprehensive laboratory analysis and on-site field evaluations to determine the properties of crude oil and refined products, alongside performing proprietary and collaborative industry research studies. Conversely, the Production Enhancement segment furnishes an array of services and products vital for well completions, perforations, stimulation processes, and general production activities. This includes providing integrated diagnostic tools designed to assess the efficacy of well completions and to devise strategies for more effective enhanced oil recovery initiatives. Core Laboratories markets and sells its solutions through diverse channels, including direct sales representatives, educational seminars, industry trade exhibitions, print advertising, and a network of distributors. Established in 1936, the company boasts a significant international presence, conducting operations in approximately 50 countries, with its corporate headquarters situated in Amstelveen, the Netherlands.
IPO date
Jul 10, 1998
Employees
3,600
Domiciled in
NL
Incorporated in
NL

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2025‑122024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT